Abstract | BACKGROUND: METHODS: The release pattern of MRP14 was analyzed in human and murine cerebrospinal fluid (CSF), as well as in isolated neutrophils. Its functional role was assessed in a mouse meningitis model, using MRP14-deficient mice. RESULTS: We detected large quantities of MRP14 in CSF specimens from patients and mice with pneumococcal meningitis. Immunohistochemical analyses and a cell-depletion approach indicated neutrophils as the major source of MRP14. In a meningitis model, MRP14-deficient mice showed a better resolution of inflammation during antibiotic therapy, which was accompanied by reduced disease severity. Intrathecal administration of MRP14 before infection reverted the phenotype of MRP14-deficient mice back to wild type. Moreover, intrathecal injection of MRP14 alone was sufficient to induce meningitis in a Toll-like receptor 4 (TLR4)-CXCL2-dependent manner. Finally, treatment with the MRP14 antagonist paquinimod reduced inflammation and disease severity significantly, reaching levels comparable to those achieved after genetic depletion of MRP14. CONCLUSIONS:
|
Authors | Christina Wache, Matthias Klein, Christian Ostergaard, Barbara Angele, Hans Häcker, Hans-Walter Pfister, Monika Pruenster, Markus Sperandio, Tomas Leanderson, Johannes Roth, Thomas Vogl, Uwe Koedel |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 212
Issue 2
Pg. 247-57
(Jul 15 2015)
ISSN: 1537-6613 [Electronic] United States |
PMID | 25605866
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: [email protected]. |
Chemical References |
- ABCC11 protein, human
- ATP-Binding Cassette Transporters
- Anti-Bacterial Agents
- Calgranulin B
- Chemokine CXCL2
- Ceftriaxone
|
Topics |
- ATP-Binding Cassette Transporters
(cerebrospinal fluid)
- Animals
- Anti-Bacterial Agents
(pharmacology, therapeutic use)
- Calgranulin B
(cerebrospinal fluid)
- Case-Control Studies
- Ceftriaxone
(pharmacology, therapeutic use)
- Chemokine CXCL2
(biosynthesis)
- Humans
- Male
- Meningitis, Pneumococcal
(cerebrospinal fluid, drug therapy, immunology)
- Mice, Inbred C57BL
- Mice, Knockout
|